According to Future Market Insights (FMI), the pet light therapy devices market is projected to grow from USD 187.4 million in 2025 to USD 429.6 million by 2036. The market is expected to reach USD 201.5 million in 2026 and expand at a 7.9% CAGR from 2026 to 2036. Laser-based devices are expected to lead product demand with 58.0% share in 2026, while pain management is projected to account for 39.0% of application demand in 2026.

Pet light therapy devices are moving from specialist rehabilitation settings into wider companion animal care. Veterinary clinics are adopting photobiomodulation where pain control, inflammation management, wound support, and mobility care require non-invasive adjunctive treatment. Dogs are projected to account for 68.0% of animal type demand in 2026, while veterinary clinics are expected to hold 61.0% of end-user demand, reflecting the importance of trained treatment setup and dose control.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-33016

Why is the Pet Light Therapy Devices Market Growing?

The market is expanding as veterinary practices adopt light therapy for pain management, inflammation, wound healing, rehabilitation, and recovery.

Pain management remains the leading application, particularly for older pets requiring ongoing arthritis and mobility care. Rehabilitation centers are also adopting light therapy alongside existing treatment programs.

Home-use devices offer additional growth potential as owners seek convenient maintenance care. Adoption depends on clear safety guidance, treatment protocols, and veterinary support.

Growing clinical evidence is strengthening purchasing decisions, increasing demand for devices with measurable output, wavelength specifications, treatment guidance, and training support.

Market Segmentation Analysis

• Laser-based devices are expected to account for 58.0% of product type demand in 2026, as veterinary clinics prefer stronger output control and shorter treatment times.
• Near-infrared light sources are projected to represent 52.0% of light source demand in 2026, supported by applications requiring deeper tissue targeting.
• Pain management is expected to hold 39.0% of application demand in 2026, with arthritis and mobility care supporting repeat treatment.
• Dogs are projected to represent 68.0% of animal type demand in 2026, reflecting substantial canine mobility-care requirements.
• Veterinary clinics are anticipated to account for 61.0% of end-user demand in 2026, as trained professionals commonly manage treatment setup and dosage.
• Direct sales are expected to account for 44.0% of distribution demand in 2026, supported by the need for demonstrations, technical assistance, and training.

Insights into the Laser-Based Product Type Segment

Laser-based devices are expected to hold 58.0% of product type demand in 2026, supported by controlled treatment parameters and repeatable protocols in veterinary clinics.

Higher-power systems require trained use, making professional channels important. Suppliers offering treatment guidance, training, and technical support can strengthen adoption and maintain an advantage.

Insights into the Near-Infrared Light Source Segment

Near-infrared devices are projected to account for 52.0% of light source demand in 2026, driven by their use in deeper tissue targeting, particularly for joint and muscle care.

The 700 nm to 1100 nm wavelength range supports their positioning in photobiomodulation. Consistent wavelength delivery and treatment parameters can strengthen confidence among veterinary professionals.

Insights into the Pain Management Application Segment

Pain management is expected to account for 39.0% of application demand in 2026, driven by arthritis and mobility-related conditions, particularly among aging dogs.

The need for recurring mobility care supports continued clinic use, as light therapy can be incorporated into scheduled pain management and rehabilitation sessions.

Insights into the Veterinary Clinic End-User Segment

Veterinary clinics are expected to account for 61.0% of end-user demand in 2026, supported by the need for trained staff to manage treatment parameters and guide pet owners.

Clinic purchasing decisions increasingly focus on protocols, output consistency, training, and technical support, making effective workflow integration important for device utilization.

Pet Light Therapy Devices Market Drivers, Restraints, and Opportunities

• Chronic mobility care drives recurring treatment for older pets.
• Rehabilitation centers are adding photobiomodulation to recovery programs.
• Home-use devices support maintenance care under veterinary guidance.
• Wound and oral recovery offer additional application opportunities.
• Training and protocol uncertainty remain key adoption barriers.
• Clear wavelength and dose specifications can strengthen manufacturer positioning.

Chronic Mobility Care

Mobility care remains a key commercial anchor because older dogs can require repeated support for pain and stiffness. Veterinary photobiomodulation applications include osteoarthritis and inflammatory conditions, giving clinics opportunities to incorporate therapy into ongoing care plans.

Dose and Protocol Requirements

The main restraint is the need for appropriate treatment protocols. Outcomes can depend on wavelength, energy delivery, treatment timing, and tissue penetration. This makes output consistency and professional training important competitive factors. Devices with limited technical documentation may face greater resistance from veterinary buyers.

Home-Care Expansion

Home-use products can expand market access as pet owners seek convenient care between clinic visits. However, product credibility and veterinary guidance remain important as the market includes lasers, LED devices, and red-light systems. Clear positioning and reliable treatment information can help reduce buyer confusion and support adoption.

Regional Market Analysis

• United States: Largest value market, growing at 6% CAGR, supported by strong clinic adoption and pet care spending.
• China: Expected to grow at 4% CAGR, driven by domestic manufacturing and wider access to affordable devices.
• Brazil: Projected to expand at 3% CAGR, supported by pain management and post-surgical applications.
• United Kingdom: Forecast to grow at 2% CAGR, backed by rehabilitation services and established veterinary care.
• Germany: Expected to register 8% CAGR, supported by technical quality and professional training.
• India: Fastest-growing market at 2% CAGR, driven by premium pet care and specialty veterinary services.
• Japan: Projected to grow at 5% CAGR, supported by non-invasive mobility care and compact therapy systems.

Competitive Landscape and Strategic Positioning

The pet light therapy devices market is moderately fragmented, with veterinary laser manufacturers, photobiomodulation specialists, and LED suppliers competing on clinical credibility, treatment protocols, output consistency, and training support.

Competition is increasingly driven by device performance and technical support, as clinics seek reliable systems with clear treatment guidance.

Lower-cost LED devices are expanding access, while established suppliers differentiate through wavelength accuracy, safety guidance, consistent output, and evidence-based applications.

Key Companies in the Pet Light Therapy Devices Market

• Veterinary Clinic System Leaders: Companion Animal Health, LiteCure, K-Laser, and Respond Systems compete through clinic-grade systems, professional training, treatment protocols, and veterinary channel access.
• PBM and Rehabilitation Specialists: Multi Radiance Medical, THOR Photomedicine, and Erchonia focus on photobiomodulation platforms and specialized treatment applications.
• Home-Use and Emerging Suppliers: MedcoVet, My Pet Laser, and Fotonmedix compete through portable systems and pet-focused products, with adoption influenced by affordability, veterinary endorsement, and safety guidance.

Analyst Perspective

“Nandini Roy Choudhury, Principal Consultant at Future Market Insights, says, “Pet light therapy is becoming a practical clinic tool when pain control and recovery support need a low-burden option. A weak device with vague wavelength claims gives poor outcomes and hurts trust in the category.”

Market Snapshot

• 2026 market value: USD 201.5 million
• 2036 projected value: USD 429.6 million
• CAGR, 2026–2036: 7.9%
• Leading product type in 2026: Laser-based devices
• Laser-based device share in 2026: 58.0%
• Leading application in 2026: Pain management
• Pain management share in 2026: 39.0%
• Leading end user in 2026: Veterinary clinics
• Veterinary clinic share in 2026: 61.0%
• Fastest-growing country: India
• India CAGR, 2026–2036: 10.2%

About the Report

The Pet Light Therapy Devices Market study by Future Market Insights covers laser and LED therapy devices, including handheld units, wearable wraps, clinic systems, and portable devices for companion animals.

The report analyzes product type, light source, application, animal type, end user, and distribution channel, covering pain management, wound care, rehabilitation, oral care, and recovery applications for dogs and cats.

Regional and country-level analysis includes the United States, China, Brazil, UK, Germany, India, and Japan, with forecasts based on pet care spending, clinic adoption, pet ownership, and equipment penetration.

FMI combines primary research and desk research, using inputs from veterinary clinics, rehabilitation centers, distributors, manufacturers, and industry literature. Market estimates consider device volumes, pricing, replacement cycles, and end-user demand, with validation against industry and supplier data.

Key companies profiled include Companion Animal Health, LiteCure, Multi Radiance Medical, Respond Systems, THOR Photomedicine, K-Laser, Erchonia, MedcoVet, My Pet Laser, and Fotonmedix.

Explore More Related Studies Published by FMI Research:

https://www.openpr.com/news/4543146/medical-ventilators-market-led-by-north-america-medtronic

https://www.openpr.com/news/4543150/alzheimer-s-therapeutics-market-dominated-by-north-america

https://www.openpr.com/news/4543154/home-healthcare-products-market-led-by-north-america-baxter

FMI Custom Research: Strategic Intelligence for Confident Decision-Making

In today's rapidly evolving healthcare environment, leadership teams need more than market data—they need actionable intelligence tailored to their strategic priorities. FMI's Custom Research solutions help organizations evaluate growth opportunities, validate investments, assess competitive dynamics, understand technology adoption, and reduce uncertainty before making critical business decisions.

Key Executive Benefits

• Decision-Ready Insights: Research tailored to specific business challenges, expansion plans, technology priorities, and investment requirements.
• Reduced Strategic Risk: Validate market opportunities, customer demand, competitive positioning, and technology adoption before committing resources.
• Market Entry Confidence: Assess opportunity size, regulatory barriers, distribution dynamics, healthcare infrastructure, and competitive landscapes.
• Competitive Advantage: Gain proprietary intelligence unavailable through syndicated reports or internal datasets.
• Faster Growth Decisions: Accelerate market expansion, product development, portfolio optimization, partnerships, and investment planning.

Business Impact

FMI helps organizations transform market complexity into strategic clarity, enabling leadership teams to identify growth opportunities faster, optimize resource allocation, strengthen competitive positioning, and make high-stakes business decisions with confidence.

To explore how FMI Custom Research can support your strategic priorities, connect with the team at sales@futuremarketinsights.com